So they used minimal doses on the SIRT arm and maximum dosages (compared to what payers will support on at least the number of months they will pay) on the sorafenib arm.
Not helpful to SRX and not real world use (not to also mention the 3 week additional delay in treatment compared to current practice).
Sirt result, page-78
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $75.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| SRX (ASX) Chart |
Day chart unavailable